Smith & Wesson Brands (NASDAQ: SWBI) Reports Strong Q4 Earnings and Financial Growth

Font: Financial Modeling Prep  • Jun 18, 2026

• Smith & Wesson Brands (NASDAQ: SWBI) exceeded analyst expectations with strong fourth-quarter revenue of $178.40 million and an EPS of $0.36.
• The company demonstrated significant profitability growth, with net income rising to $16.20 million and a quarterly gross margin of 29.80%.
• Smith & Wesson Brands maintains a strong financial position, evidenced by a current ratio of 3.20 and $74.60 million in cash generated from operations.

Smith & Wesson Brands (NASDAQ: SWBI) is a leading American firearms manufacturer. On June 17, 2026, Smith & Wesson Brands reported strong fourth-quarter results after the market closed. This positive Q4 earnings news caused the company's stock to rise, as highlighted by Benzinga, reflecting strong market confidence in the firearms industry.

The company announced revenue of $178.40 million, easily beating analyst expectations of $155.27 million. This represents a 26.70% increase from the same quarter last year, showcasing significant revenue growth. The Wall Street Journal notes this growth is driven by strong handgun sales and market share gains for Smith & Wesson Brands.

Smith & Wesson Brands also surpassed earnings estimates. It reported an earnings per share (EPS) of $0.36, which is higher than the expected $0.23. This strong profitability comes from a net income of $16.20 million, a large increase from $8.60 million in the prior year's quarter, signaling robust financial performance.

The company's profitability improved, with its quarterly gross margin reaching 29.80%. Smith & Wesson also generated $74.60 million in cash from its operations. This demonstrates the company's effective business management and strong operational efficiency in converting sales into cash.

From a financial health perspective, Smith & Wesson Brands has a current ratio of 3.20. This liquidity ratio suggests the company has more than enough assets to cover its short-term liabilities. The stock has a trailing price-to-earnings (P/E) ratio of 38.72, offering key investment insights.